We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Enzon Inc (QX) | USOTC:ENZN | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.00455 | -5.17% | 0.08345 | 0.07 | 0.095 | 0.08345 | 0.072 | 0.07455 | 900 | 21:20:00 |
FORM 3
| Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * COUCHMAN JONATHAN |
2. Date of Event Requiring Statement (MM/DD/YYYY)
| 3. Issuer Name and Ticker or Trading Symbol ENZON PHARMACEUTICALS, INC. [ENZN] |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director ___X___ 10% Owner _____ Officer (give title below) _____ Other (specify below) | ||
5. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned | |||
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock, par value $0.01 per share (1) | 4717666 | I | By Jonathan Couchman (2) |
Common Stock, par value $0.01 per share (1) | 400000 | I | By Couchman Family Fund (3) |
Common Stock, par value $0.01 per share (1) | 2100524 | I | By Xstelos Corp. (4) |
Common Stock, par value $0.01 per share (1) | 633264 | I | By Myrexis, Inc. (5) |
Common Stock, par value $0.01 per share (1) | 1667294 | I | By Harper Asset Management LLC (6) |
Common Stock, par value $0.01 per share (1) | 0 | I | By Michael Pearce (7) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
COUCHMAN JONATHAN 600 FIFTH AVENUE 2ND FLOOR NEW YORK, NY 10020 | X | ||||
Couchman Family Fund 600 FIFTH AVENUE 2ND FLOOR NEW YORK, NY 10020 | X | ||||
Xstelos Corp. 1105 NORTH MARKET STREET SUITE 1300 WILMINGTON, DE 19801 | X | ||||
Myrexis, Inc. 600 FIFTH AVENUE 2ND FLOOR NEW YORK, NY 10020 | X | ||||
Harper Brian James 2248 MARINER DR. LONGMONT, CO 80503 | See explanation of responses | ||||
HARPER ASSET MANAGEMENT LLC 2248 MARINER DR. LONGMONT, CO 80503 | See explanation of responses | ||||
Pearce Michael Cooper 193 AUDUBON TRAIL CASHIERS, NC 28717 | See explanation of responses |
Signatures | ||
/s/ Jonathan Couchman | 8/6/2020 | |
**Signature of Reporting Person | Date | |
Couchman Family Fund; By: /s/ Jonathan Couchman, Trustee | 8/6/2020 | |
**Signature of Reporting Person | Date | |
Xstelos Corp.; By: /s/ Jonathan Couchman, Chief Executive Officer | 8/6/2020 | |
**Signature of Reporting Person | Date | |
Myrexis, Inc.; By: /s/ Jonathan Couchman, Chief Executive Officer | 8/6/2020 | |
**Signature of Reporting Person | Date | |
/s/ Jonathan Couchman, attorney-in-fact for Brian Harper | 8/6/2020 | |
**Signature of Reporting Person | Date | |
Harper Asset Management, LLC; By: /s/ Brian Harper | 8/6/2020 | |
**Signature of Reporting Person | Date | |
/s/ Jonathan Couchman, attorney-in-fact for Michael Pearce | 8/6/2020 | |
**Signature of Reporting Person | Date |
1 Year Enzon (QX) Chart |
1 Month Enzon (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions